Avantor, Inc. (NYSE:AVTR) Shares Acquired by Perpetual Ltd

Perpetual Ltd lifted its position in Avantor, Inc. (NYSE:AVTR) by 38.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,766,882 shares of the company’s stock after acquiring an additional 493,408 shares during the quarter. Perpetual Ltd owned 0.26% of Avantor worth $37,228,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Public Employees Retirement System of Ohio grew its position in shares of Avantor by 34.1% during the third quarter. Public Employees Retirement System of Ohio now owns 346,822 shares of the company’s stock worth $8,972,000 after acquiring an additional 88,205 shares during the last quarter. New York State Teachers Retirement System bought a new stake in Avantor in the third quarter worth about $8,473,000. Everence Capital Management Inc. bought a new stake in Avantor during the fourth quarter worth approximately $555,000. Teachers Retirement System of The State of Kentucky raised its position in shares of Avantor by 45.8% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 723,178 shares of the company’s stock worth $18,708,000 after purchasing an additional 227,200 shares during the period. Finally, Principal Financial Group Inc. lifted its stake in Avantor by 146.5% during the third quarter. Principal Financial Group Inc. now owns 2,628,372 shares of the company’s stock valued at $67,996,000 after buying an additional 1,562,018 shares in the last quarter. 95.08% of the stock is owned by institutional investors and hedge funds.

Avantor Stock Down 1.9 %

Shares of AVTR opened at $22.14 on Tuesday. The company has a 50-day moving average price of $21.45 and a two-hundred day moving average price of $23.39. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. The stock has a market cap of $15.07 billion, a price-to-earnings ratio of 48.13, a P/E/G ratio of 3.51 and a beta of 1.28. Avantor, Inc. has a 12 month low of $19.59 and a 12 month high of $28.00.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on AVTR. UBS Group reiterated a “neutral” rating and set a $25.00 price target (down previously from $29.00) on shares of Avantor in a report on Friday. Barclays lowered their price target on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Friday, October 25th. Robert W. Baird lowered their target price on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research report on Monday, October 28th. Wells Fargo & Company dropped their price target on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $34.00 price objective on shares of Avantor in a research report on Thursday, September 26th. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $27.38.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.